Table 11 Zone of Inhibition between wafer formulation and standard drug.
From: Calcium alginate medicated dressing for enhanced absorption in diabetic foot ulcer management
Organism Average | Average ZOI (mm) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Wafer discs (mg/ml) | Linezolid(µg/ml) | ||||||||
0.25 | 0.50 | 25.0 | 0.5 | 1 | 2 | 4 | 8 | 16 | |
Methicillin-resistant Staphylococcus aureus ATCC 43,300. | 52.7 | 61.6 | 68.1 | 9.4 | 11.6 | 13.8 | 19.4 | 23.6 | 27.2 |